§ Joan RuddockTo ask the Secretary of State for Health pursuant to the answer of 17 December,Official Report,
Department of Health Vacancies Survey Health visitor three month vacancies in NHS trusts by Government office region—three month vacancy rates, numbers and staff in post 3 month vacancy rate (percentage)
3 month vacancy number
Staff in post (whole time equivalent)
Staff in post (headcount)
March 1999 September 1998 England 1.0 99 10,068 12,572 East Midlands 0.4 3 796 988 East of England 1.5 14 913 1,192 London 2.2 36 1,622 1,965 North East 0.4 2 564 658 North West 0.2 3 1,591 1,911 South East 1.4 21 1,484 1,984 South West 0.4 4 946 1,205 West Midlands 0.5 5 1,105 1,346 Yorkshire and the Humber 1.1 11 1,046 1,323 464W
Department of Health Vacancies Survey Health visitor three month vacancies in NHS trusts by Government office region—three month vacancy rates, numbers and staff in post 3 month vacancy rate (percentage)
3 month vacancy number
Staff in post (whole time equivalent)
Staff in post (headcount)
March 2000 September 1999 England 1.9 192 10,161 12,800 East Midlands 1.4 11 811 1,037 East of England 4.0 36 883 1,135 London 3.3 57 1,693 2,052 North East 0.4 3 569 659 North West 2.6 42 1,588 1,903 South East 1.2 19 1,524 2,084 South West 0.3 3 920 1,189 West Midlands 1.2 14 1,132 1,420 Yorkshire and the Humber 0.6 6 1,040 1,321 column 995W, on genetically modified food, whether safety testing for Bt11 sweetcorn was carried out on sweetcorn destined for human consumption. [146327]
§ Miss Melanie JohnsonThe safety of Bt11 sweetcorn has been evaluated under the procedures set out in Regulation (EC) No 258/97 and according to the European Community Scientific Committee on Food's scheme for the safety assessment of genetically modified foods. The safety assessment involved detailed analysis of both the Bt11 field maize and Bt11 sweetcorn intended for human consumption. The Scientific Committee on Food was satisfied on the basis of all the information provided that the Bt11 sweetcorn was as safe as its conventional counterpart.